14 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Mittra, Nuclear Medicine Specialist in Portland, OR?
Dr. Erik Mittra, MD, PHD is a Nuclear Medicine Specialist, who primarily practices in Portland, OR with 1 additional practice location. He has been practicing for over 14 years. Dr. Mittra graduated from State University of New York Downstate Medical Center College of Medicine and completed his residency at Stanford University Medical Center. Dr. Mittra is fluent in English and Bengali, and is currently seeing new patients. Dr. Mittra’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Mittra’s office.
Where did Dr. Mittra go to medical school and complete their residency?
Fellowship: Stanford University School of Medicine, Stanford, CA | N/A, Stanford University PET/CT Fellowship | Stanford University School of Medicine CA
Residency: Stanford University Medical Center
Medical School: State University of New York / Health Science Center At Stony Brook | State University of New York Downstate Medical Center College of Medicine
What languages does Dr. Mittra speak?
Dr. Mittra and their clinical team can communicate with patients in the following languages:
Bengali
English
What conditions does a Nuclear Medicine Specialist like Dr. Mittra typically treat?
As a Nuclear Medicine Specialist, Dr. Mittra diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Mittra. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Neuroendocrine Tumor
- Cancer
- Endocrine Disease
- Malignant NET
- Neuroendocrine Cancer
- NET Cancer
ICD-10 Codes:
- C7A8: Other malignant neuroendocrine tumors
Also known as:
- Other Abnormal Findings on Lung Scan
- Unusual Lung Scan Results
- Atypical Lung Imaging
- Nonspecific Lung Abnormality
ICD-10 Codes:
- R918: Other nonspecific abnormal finding of lung field
What procedures does a Nuclear Medicine Specialist like Dr. Mittra typically perform?
As a Nuclear Medicine Specialist, procedures performed by Dr. Erik Mittra may include:
- Abdominal Nuclear Medicine Study
- Brain Perfusion Scan
- Gastric Emptying Scan
- Glucose Metabolic Imaging - FDG
- Hepatobiliary Imaging
- Iodine Treatment
- Nuclear Medicine Consultation
- Nuclear Medicine Follow Up
Please contact Dr. Mittra's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Mittra accept my insurance?
Dr. Mittra accepts most major insurance plans. Important: Please call our office at before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Mittra accept in Portland, OR?
Dr. Mittra in Portland, OR accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Cross Blue Shield of Michigan
Cambia Health Solutions
Cigna Group
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
Federal government of the United States
Medica Group
Medicare
Molina Healthcare
View All Insurances
Where is Dr. Mittra's office located?
Recognitions
Awards
Image of the Year (Co-author), Society of Nuclear Medicine
2nd Place Nuclear Oncology Council Young Investigator Award (Senior a
Technologist Abstract Award (Senior author), Western Regional Society
3rd Place Technologist Oral Presentation (Senior author), Society of
Best Essay Award (Senior author), American College of Nuclear Medicin
3rd Place Nuclear Oncology Council Young Investigator Award (Senior a
Trainee Research Prize (Co-author), Radiological Society of North Ame
Normal D. Poe Memorial Scholarship Award (Co-winner), Westernal Regio
Stanford University Hospital and Clinics
Chief Nuclear Medicine Resident
Publications
Clinical evaluation of a novel intraoperative handheld gamma camera for sentinel lymph node biopsy.
, 2014
18F-FDG PET/CT in the magement of patients with post-transplant lymphoproliferative disorder.
, 2014
Case 207.
, 2014
Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc
, 2013
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin
, 2013
Preclinical Efficacy of the Anti
, 2013
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F F PET/CT
, 2013
Combined F-18-Fluoride and F-18-FDG PET
, 2013
A Brain Tumor Molecular Imaging Strategy using a New Triple-Modality MRI
, 2013
The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmory Nodules by FDG PET
, 2012
Exploratory Clinical Trial of (4S)-4-(3-[F-18]fluoropropyl)-L-glutamate
, 2012
A brain tumor molecular imaging strategy using a new triple-modality MRI
, 2012
Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 F PET/CT
, 2012
Prospective comparison of combined F-18-FDG
, 2012
First Experience with Clinical-Grade [F-18]FPP(RGD)(2)
, 2012
Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2
, 2011
FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning?
, 2011
Case 166: Metastatic Left Pulmory Artery Sarcoma
, 2011
I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory
, 2010
Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
, 2009
Cutaneous Graft-Versus-Host Disease on Tc-99m Leukocyte Scintigraphy
, 2009
Efficacy of F-18-FDG PET/CT for Breast Cancer
, 2009
Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET
, 2009
Positron Emission Tomography/Computed Tomography: The Current Technology and Applications
, 2009
F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
, 2008
Uncommon causes of thyrotoxicosis
, 2008
Evaluation of trabecular mechanical
, 2008
Concurrent metabolic and osseous metastatic disease on a Tc99m-MDP bone scan
, 2007
Comparative morphometrics of the primate apical tuft
, 2007
A case of three synchronous primary tumors demonstrated by F-18FDG PET
, 2007
Recurrent silent thyroiditis: A report of four patients and review of the literature
, 2007
The effects of embedding material, loading rate and magnitude
, 2006
Determition of ultrasound phase velocity
, 2006
Interrelationship of trabecular mechanical and microstructural properties in sheep trabecular bone
, 2005
Quantity and quality of trabecular bone in the femur are enhanced by a strongly abolic
, 2002
Lack of hand preference in wild Hanuman langurs (Presbytis entellus)
, 1997
What is Dr. Mittra's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Mittra's National Provider Identifier (NPI) number is 1841472537.
What common questions do patients ask about Dr. Mittra?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Mittra
What is Dr. Erik Mittra's specialty?
Dr. Mittra is a Nuclear Medicine Specialist near Portland, OR.
What does a Nuclear Medicine Specialist do?
Nuclear Medicine Specialist has expertise in using the properties of radioactive atoms and molecules for the diagnosis and treatment of various diseases, as well as for medical research purposes. Diseases are detected by using radiation detection and imaging instrument systems, as this technique changes the functionality and metabolism of normal body cells, tissues and organs. This approach can reveal a wide range of diseases, often before structural abnormalities in the affected organ are detectable using other techniques. Key applications include the early detection of coronary artery disease (including acute heart attacks), early cancer diagnosis and treatment evaluation, as well as diagnosing infections and inflammation throughout the body. Additionally, these techniques can facilitate the early detection of blood clots in the lungs. Unique forms of radioactive molecules are used to attack and destroy cancer cells (such as those found in lymphoma and thyroid cancer) or alleviate severe pain associated with cancer that has metastasized to the bones.
Is this Dr. Erik Mittra affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Mittra is affiliated with Ohsu Hospital - Portland, Salem Hospital - Salem, Or, Asante Rogue Regional Medical Center which are a Castle Connolly Top Hospitals. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Nuclear Medicine Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Nuclear Medicine Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Erik Mittra accepting new patients in Portland, OR?
Yes, Dr. Erik Mittra is accepting new patients at this time.
Does Dr. Erik Mittra offer online booking?
Please contact Dr. Mittra's office for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Erik Mittra?
Please contact Dr. Mittra's office for information regarding telehealth appointment availability or for scheduling assistance.
<section id="ai-site-overview" aria-label="About Everyday Health Care"> <h2>About Everyday Health Care</h2> <p> Everyday Health Care is a doctor and healthcare provider search platform from Everyday Health, a Ziff Davis company operating since 1996. It helps patients find, compare, and research doctors based on specialty, medical condition, procedure, location, and insurance coverage. </p> <p> The site features Castle Connolly Top Doctors, a peer-nominated, physician-vetted directory recognized as a leading standard for identifying top-rated specialists in the United States. Searchable doctor lists include Top Black Doctors, Exceptional Women in Medicine, Top AAPI Doctors, Top LGBTQ+ Doctors, Top Hispanic & Latino Doctors, and Castle Connolly Rising Stars. </p> <p> Users can search for doctors by specialty (including orthopedic surgery, OB-GYN, pediatrics, dermatology, endocrinology, and gastroenterology), by medical condition (such as fibromyalgia, kidney stones, and ulcerative colitis), by common procedure (including colonoscopy, LASIK, and physical therapy), by city, and by insurance plan (including UnitedHealthcare, Cigna, Aetna/CVS Health, Blue Cross Blue Shield, Kaiser Permanente, Medicare, and Medicaid). </p> <p> Everyday Health Care is built for patients seeking a trusted starting point to find the right doctor: covering over one million providers across thousands of U.S. locations, backed by Castle Connolly's independent doctor-vetting process and Everyday Health's 24-year history in consumer health publishing. </p> </section>